Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients

被引:50
作者
Moriya, Hidekazu
Oka, Machiko
Maesato, Kyoko
Mano, Tsutomu
Ikee, Ryota
Ohtake, Takayasu
Kobayashi, Shuzo [1 ]
机构
[1] Shonan Kamakura Gen Hosp, Dept Nephrol, Kamakura, Kanagawa 2478533, Japan
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 3卷 / 02期
关键词
D O I
10.2215/CJN.03490807
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: With regard to monitoring blood pressure in hemodialysis patients, it is important to define clearly the time point at which the blood pressure is measured, because the blood pressure of hemodialysis patients varies with each hemodialysis session as a result of loss of excess fluid. Design, setting, participants, & measurements: Using weekly averaged blood pressure, 96 hemodialysis patients were studied prospectively for 35 mo. All patients were followed up for cardiovascular events or death from all causes. Results: Pulse weekly averaged blood pressure and age at enrollment were significantly higher and parathyroid hormone level was significantly lower in patients with cardiovascular events compared with those without cardiovascular events; however, none of the components of pre- or postdialysis blood pressure was significantly different between patients with and without cardiovascular events. Pulse weekly averaged blood pressure, prepulse pressure, age, and human atrial natriuretic peptide were significantly higher in patients who died than in survivors. Kaplan-Meier method with a log-rank test demonstrated that survival free rate from cardiovascular events and that of all-cause mortality in patients with pulse weekly averaged blood pressure >= 70 mmHg were significantly lower than those in the remaining patients. Conclusions: One-point measurement of blood pressure is insufficient to evaluate hypertension and prognosis of hemodialysis patients, and weekly averaged blood pressure is a useful marker because of averaging fluctuations of blood pressure during 1 wk. Among components of weekly averaged blood pressure, pulse weekly averaged blood pressure could be a good prognostic marker of the incidence of both cardiovascular events and all-cause mortality in hemodialysis patients.
引用
收藏
页码:416 / 422
页数:7
相关论文
共 32 条
[1]   Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients [J].
Agarwal, R ;
Andersen, MJ ;
Bishu, K ;
Saha, C .
KIDNEY INTERNATIONAL, 2006, 69 (05) :900-906
[2]   Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy [J].
Agarwal, R ;
Brim, NJ ;
Mahenthiran, J ;
Andersen, MJ ;
Saha, C .
HYPERTENSION, 2006, 47 (01) :62-68
[4]   Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients [J].
Amar, J ;
Vernier, I ;
Rossignol, E ;
Bongard, V ;
Arnaud, C ;
Conte, JJ ;
Salvador, M ;
Chamontin, B .
KIDNEY INTERNATIONAL, 2000, 57 (06) :2485-2491
[5]   Pulse pressure -: A predictor of long-term cardiovascular mortality in a French male population [J].
Benetos, A ;
Safar, M ;
Rudnichi, A ;
Smulyan, H ;
Richard, JL ;
Ducimetière, P ;
Guize, L .
HYPERTENSION, 1997, 30 (06) :1410-1415
[6]   Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease [J].
Blacher, J ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
Safar, ME ;
London, GM .
HYPERTENSION, 1998, 32 (03) :570-574
[7]   Increased pulse pressure and risk of heart failure in the elderly [J].
Chae, CU ;
Pfeffer, MA ;
Glynn, RJ ;
Mitchell, GF ;
Taylor, JO ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (07) :634-639
[8]   Importance of treatment time and blood pressure control in achieving long-term survival on dialysis [J].
Charra, B ;
Calemard, E ;
Laurent, G .
AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (01) :35-44
[9]   Pulse pressure - A review of mechanisms and clinical relevance [J].
Dart, AM ;
Kingwell, BA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (04) :975-984
[10]   MORTALITY RISK-FACTORS IN PATIENTS TREATED BY CHRONIC-HEMODIALYSIS - REPORT OF THE DIAPHANE COLLABORATIVE STUDY [J].
DEGOULET, P ;
LEGRAIN, M ;
REACH, I ;
AIME, F ;
DEVRIES, C ;
ROJAS, P ;
JACOBS, C .
NEPHRON, 1982, 31 (02) :103-110